ImageneBio raises ~$30M via pre-funded warrants to fund atopic dermatitis and alopecia areata programs

ImageneBio, Inc.

Gross proceeds of ~$30M from sale of pre-funded warrants for 5.77M shares at $5.199 each.
Closing expected April 14, 2026; warrants exercisable at $0.001, no expiration.
Proceeds to fund late-phase development in atopic dermatitis and expand IMG-007 into alopecia areata.
Registration rights agreement requires filing by early August 2026; cash penalties for delays.
Beneficial ownership limitation set at 19.99% per investor.

item 1.01 item 3.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-151942
form_type: 8-K
ticker: IMA
cik: 0001835579
company_name: ImageneBio, Inc.
filed_at: 2026-04-13T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.070772+00:00
generated_at: 2026-05-15T06:36:40.294846+00:00
sec_items: ["1.01", "3.02", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-151942
json_url: https://secwatch.observer/filing/0001193125-26-151942.json
markdown_url: https://secwatch.observer/filing/0001193125-26-151942.md
text_url: https://secwatch.observer/filing/0001193125-26-151942.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/0001193125-26-151942-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/d143873d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-151942

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.